0001209191-19-059773.txt : 20191209 0001209191-19-059773.hdr.sgml : 20191209 20191209195931 ACCESSION NUMBER: 0001209191-19-059773 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191205 FILED AS OF DATE: 20191209 DATE AS OF CHANGE: 20191209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BORKAR RATAN S CENTRAL INDEX KEY: 0001720077 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 191276342 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-05 0 0000353569 QUIDEL CORP /DE/ QDEL 0001720077 BORKAR RATAN S 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 0 SVP, Intl Comm Operations Common Stock 2019-12-05 4 M 0 4700 23.41 A 14004 D Common Stock 2019-12-05 4 S 0 4700 70.00 D 9304 D Common Stock 2019-12-06 4 M 0 368 23.41 A 9672 D Common Stock 2019-12-06 4 M 0 10754 15.40 A 20426 D Common Stock 2019-12-06 4 S 0 11122 70.00 D 9304 D Non-Qualified Stock Option 23.41 2019-12-05 4 M 0 4700 0.00 D 2025-02-05 Common Stock 4700 368 D Non-Qualified Stock Option 23.41 2019-12-06 4 M 0 368 0.00 D 2025-02-05 Common Stock 368 0 D Non-Qualified Stock Option 15.40 2019-12-06 4 M 0 10754 0.00 D 2026-02-10 Common Stock 10754 5376 D 10,754 shares vested on 2/5/2017; 5,376 vested on 2/5/2018; and 5,376 shares vested on 2/5/2019. 10,754 shares vested on 2/10/2018; 5,376 vested on 2/10/2019; and 5,376 shares will vest on 2/10/2020. All transactions reported herein were effected pursuant to a pre-established 10b5-1 trading plan. Robert J. Bujarski, attorney-in-fact for Ratan S. Borkar 2019-12-09